Opportunities and challenges of three-dimensional printing technology in pharmaceutical formulation development

被引：55

作者：

Cui, Mengsuo ^{[1
]}

Pan, Hao ^{[2
]}

Su, Yupei ^{[1
]}

Fang, Dongyang ^{[1
]}

Qiao, Sen ^{[1
]}

Ding, Pingtian ^{[1
]}

Pan, Weisan ^{[1
]}

机构：

[1] Shenyang Pharmaceut Univ, Sch Pharm, Dept Pharmaceut, Shenyang 110016, Peoples R China

[2] Liaoning Univ, Sch Pharm, 66 Chongshan Middle Rd, Shenyang 110036, Peoples R China

来源：

ACTA PHARMACEUTICA SINICA B | 2021年 / 11卷 / 08期

关键词：

Three-dimensional printing technology; Drug delivery system; Pharmaceutical; Personalized medicine; Additive manufacturing; On-demand manufacturing; Advantages; Limitations and challenges; DEPOSITION MODELING FDM; DRUG-DELIVERY DEVICES; ORAL DOSAGE FORMS; CONTROLLED-RELEASE; INNOVATIVE APPROACH; MELT EXTRUSION; 3D; TABLETS; FABRICATION; STEREOLITHOGRAPHY;

D O I：

10.1016/j.apsb.2021.03.015

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Three-dimensional printing is a technology that prints the products layer-by-layer, in which materials are deposited according to the digital model designed by computer aided design (CAD) software. This technology has competitive advantages regarding product design complexity, product personalization, and on-demand manufacturing. The emergence of 3D technology provides innovative strategies and new ways to develop novel drug delivery systems. This review summarizes the application of 3D printing technologies in the pharmaceutical field, with an emphasis on the advantages of 3D printing technologies for achieving rapid drug delivery, personalized drug delivery, compound drug delivery and customized drug delivery. In addition, this article illustrates the limitations and challenges of 3D printing technologies in the field of pharmaceutical formulation development. (C) 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.

引用

页码：2488 / 2504

页数：17

共 160 条

[51]

Huang, 2019, ADV ENG MATER, V21

[52] Additive manufacturing and its societal impact: a literature review [J].

Huang, Samuel H. ;

Liu, Peng ;

Mokasdar, Abhiram ;

Hou, Liang .

INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY, 2013, 67 (5-8) :1191-1203

[53]

[黄卫东 HUANG Wei-dong], 2009, [中国新药杂志, Chinese Journal New Drugs], V18, P1989

[54]

Hull C, 1986, US Patent, Patent No. [USA Patent 4,575,330, 4575330, 4,575,330]

[55] Powder bed 3D-printing of highly loaded drug delivery devices with hydroxypropyl cellulose as solid binder [J].

Infanger, Sophia ;

Haemmerli, Alexander ;

Iliev, Simona ;

Baier, Andrea ;

Stoyanov, Edmont ;

Quodbach, Julian .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 555 :198-206

[56] 3D Printing Technologies: Recent Development and Emerging Applications in Various Drug Delivery Systems [J].

Jacob, Shery ;

Nair, Anroop B. ;

Patel, Vimal ;

Shah, Jigar .

AAPS PHARMSCITECH, 2020, 21 (06)

[57] 3D-printing porosity: A new approach to creating elevated porosity materials and structures [J].

Jakus, A. E. ;

Geisendorfer, N. R. ;

Lewis, P. L. ;

Shah, R. N. .

ACTA BIOMATERIALIA, 2018, 72 :94-109

[58] 3D Printing in Pharmaceutical and Medical Applications - Recent Achievements and Challenges [J].

Jamroz, Witold ;

Szafraniec, Joanna ;

Kurek, Mateusz ;

Jachowicz, Renata .

PHARMACEUTICAL RESEARCH, 2018, 35 (09)

[59] 3D printing in pharmaceutics: A new tool for designing customized drug delivery systems [J].

Jonathan, Goole ;

Karim, Amighi .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 499 (1-2) :376-394

[60]

Karavasili C, 2020, EUR J PHARM SCI, V147, DOI 10.1016/j.ejps.2020.105291

← 1 2 3 4 5 6 7 8 9 10 →